Insider Selling: Chemed Co. (NYSE:CHE) Director Sells 200 Shares of Stock

Chemed Co. (NYSE:CHE) Director George J. Walsh III sold 200 shares of Chemed stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Chemed Trading Down 0.9 %

CHE opened at $571.76 on Friday. Chemed Co. has a 12-month low of $492.84 and a 12-month high of $654.62. The firm has a market capitalization of $8.66 billion, a PE ratio of 30.77, a P/E/G ratio of 2.40 and a beta of 0.43. The firm has a 50 day moving average of $552.83 and a two-hundred day moving average of $580.84.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The business had revenue of $595.88 million for the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the business posted $4.71 earnings per share. As a group, analysts predict that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Monday, August 12th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Monday, August 12th. Chemed’s payout ratio is 10.76%.

Hedge Funds Weigh In On Chemed

Institutional investors have recently made changes to their positions in the company. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Chemed in the 1st quarter valued at $1,064,000. ProShare Advisors LLC boosted its stake in Chemed by 6,288.9% during the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the last quarter. Cim LLC acquired a new stake in Chemed during the 4th quarter worth $1,328,000. Sei Investments Co. boosted its stake in Chemed by 4.5% during the 1st quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock worth $26,535,000 after purchasing an additional 1,780 shares during the last quarter. Finally, American National Bank & Trust Co. VA acquired a new stake in Chemed during the 1st quarter worth $3,122,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Royal Bank of Canada reduced their price target on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a research report on Tuesday, May 21st.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.